Ibrutinib Hfcc
Generic Name: ibrutinib hfcc
Dosage form: POWDER. Active ingredients: IBRUTINIB (100 kg/100kg). Category: BULK INGREDIENT.
Overview
Dosage form: POWDER. Active ingredients: IBRUTINIB (100 kg/100kg). Category: BULK INGREDIENT.
Dosage
Available as powder.
Related Medications
Vanzacaftor, Tezacaftor, And Deutivacaftor
vanzacaftor, tezacaftor, and deutivacaftor
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]
11 DESCRIPTION ALYFTREK (vanzacaftor, tezacaftor, and deutivacaftor tablets) are fixed-dose combination tablets for oral use available as: 10 mg of vanzacaftor (equivalent to 10.6 mg of vanzacaftor calcium dihydrate), 50 mg of tezacaftor, 125 mg of deutivacaftor or 4 mg of vanzacaftor (equivalent to 4.24 mg of vanzacaftor calcium dihydrate), 20 mg of tezacaftor, 50 mg of deutivacaftor.
Lotilaner, Moxidectin, Praziquantel, And Pyrantel
lotilaner, moxidectin, praziquantel, and pyrantel
Dosage form: TABLET, CHEWABLE. Active ingredients: LOTILANER (225 mg/1); MOXIDECTIN (.225 mg/1); PRAZIQUANTEL (57 mg/1); PYRANTEL PAMOATE (57 mg/1). Category: DRUG FOR FURTHER PROCESSING.
Binimetinib
binimetinib
11 DESCRIPTION Binimetinib is a kinase inhibitor. The chemical name is 5-[(4-bromo-2-fluorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide. The molecular formula is C 17 H 15 BrF 2 N 4 O 3 and the molecular weight is 441.2 daltons. The chemical structure of binimetinib is shown below: Binimetinib is a white to slightly yellow powder.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.